Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Crowley

Showing results (71-80 of 178) with videos related to

Pageof 18
Sort By:
Nature Biotechnology|November 26, 2020
Supporting US public health expertsRon Cohen, Cedric Francois, John Crowley, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 4, 2007
The IASLC Lung Cancer Staging Project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancerRamón Rami-Porta, David Ball, John Crowley, et al.
British Journal of Haematology|April 7, 2009
Cytogenetic abnormalities in multiple myeloma: poor prognosis linked to concomitant detection in random and focal lesion bone marrow samples and associated with high-risk gene expression profileYiming Zhou, Bijay Nair, John D Shaughnessy, et al.
British Journal of Haematology|February 28, 2008
Sustained complete remissions in multiple myeloma linked to bortezomib in total therapy 3: comparison with total therapy 2Mauricio Pineda-Roman, Maurizio Zangari, Jeff Haessler, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 5, 2009
The IASLC Lung Cancer Staging Project: proposals regarding the relevance of TNM in the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancerEric Vallières, Frances A Shepherd, John Crowley, et al.
Clinical Lymphoma & Myeloma|June 27, 2006
Superior 12-year survival after at least 4-year continuous remission with tandem transplantations for multiple myelomaBart Barlogie, Maurizio Zangari, Vanessa Bolejack, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 20, 2008
Bortezomib plus gemcitabine/carboplatin as first-line treatment of advanced non-small cell lung cancer: a phase II Southwest Oncology Group Study (S0339)Angela M Davies, Kari Chansky, Primo N Lara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2014
Historical controls for metastatic pancreatic cancer: benchmarks for planning and analyzing single-arm phase II trialsPhilip A Philip, Kari Chansky, Michael LeBlanc, et al.
Cancer|April 25, 2008
Completion of premaintenance phases in total therapies 2 and 3 improves clinical outcomes in multiple myeloma: an important variable to be considered in clinical trial designsBart Barlogie, Jeff Haessler, Mauricio Pineda-Roman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 25, 2016
The IASLC Lung Cancer Staging Project: Methodology and Validation Used in the Development of Proposals for Revision of the Stage Classification of NSCLC in the Forthcoming (Eighth) Edition of the TNM Classification of Lung CancerFrank C Detterbeck, Kari Chansky, Patti Groome, et al.
Pageof 18

Showing results (71-80 of 178) with videos related to

Sort By:
Pageof 18
Nature Biotechnology|November 26, 2020
Supporting US public health expertsRon Cohen, Cedric Francois, John Crowley, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 4, 2007
The IASLC Lung Cancer Staging Project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancerRamón Rami-Porta, David Ball, John Crowley, et al.
British Journal of Haematology|April 7, 2009
Cytogenetic abnormalities in multiple myeloma: poor prognosis linked to concomitant detection in random and focal lesion bone marrow samples and associated with high-risk gene expression profileYiming Zhou, Bijay Nair, John D Shaughnessy, et al.
British Journal of Haematology|February 28, 2008
Sustained complete remissions in multiple myeloma linked to bortezomib in total therapy 3: comparison with total therapy 2Mauricio Pineda-Roman, Maurizio Zangari, Jeff Haessler, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 5, 2009
The IASLC Lung Cancer Staging Project: proposals regarding the relevance of TNM in the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancerEric Vallières, Frances A Shepherd, John Crowley, et al.
Clinical Lymphoma & Myeloma|June 27, 2006
Superior 12-year survival after at least 4-year continuous remission with tandem transplantations for multiple myelomaBart Barlogie, Maurizio Zangari, Vanessa Bolejack, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 20, 2008
Bortezomib plus gemcitabine/carboplatin as first-line treatment of advanced non-small cell lung cancer: a phase II Southwest Oncology Group Study (S0339)Angela M Davies, Kari Chansky, Primo N Lara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2014
Historical controls for metastatic pancreatic cancer: benchmarks for planning and analyzing single-arm phase II trialsPhilip A Philip, Kari Chansky, Michael LeBlanc, et al.
Cancer|April 25, 2008
Completion of premaintenance phases in total therapies 2 and 3 improves clinical outcomes in multiple myeloma: an important variable to be considered in clinical trial designsBart Barlogie, Jeff Haessler, Mauricio Pineda-Roman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 25, 2016
The IASLC Lung Cancer Staging Project: Methodology and Validation Used in the Development of Proposals for Revision of the Stage Classification of NSCLC in the Forthcoming (Eighth) Edition of the TNM Classification of Lung CancerFrank C Detterbeck, Kari Chansky, Patti Groome, et al.
Pageof 18